138 related articles for article (PubMed ID: 34219715)
21. Age-Related Association Between APOE ɛ4 and Cognitive Progression in de novo Parkinson's Disease.
Liu JY; Ma LZ; Wang J; Cui XJ; Sheng ZH; Fu Y; Li M; Ou YN; Yu JT; Tan L; Lian Y
J Alzheimers Dis; 2023; 91(3):1121-1132. PubMed ID: 36565124
[TBL] [Abstract][Full Text] [Related]
22. Association between polygenic risk for Alzheimer's disease, brain structure and cognitive abilities in UK Biobank.
Tank R; Ward J; Flegal KE; Smith DJ; Bailey MES; Cavanagh J; Lyall DM
Neuropsychopharmacology; 2022 Jan; 47(2):564-569. PubMed ID: 34621014
[TBL] [Abstract][Full Text] [Related]
23. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E epsilon 4 allele is associated with ventricular expansion rate and surface morphology in dementia and normal aging.
Roussotte FF; Gutman BA; Madsen SK; Colby JB; Narr KL; Thompson PM;
Neurobiol Aging; 2014 Jun; 35(6):1309-17. PubMed ID: 24411483
[TBL] [Abstract][Full Text] [Related]
25. Subjective Cognitive Decline and APOE ɛ4: A Systematic Review.
Ali JI; Smart CM; Gawryluk JR
J Alzheimers Dis; 2018; 65(1):303-320. PubMed ID: 30040718
[TBL] [Abstract][Full Text] [Related]
26. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
[TBL] [Abstract][Full Text] [Related]
27. Interaction of white matter hyperintensities (WMHs) and apolipoprotein E (APOE) genotypes on cognition in patients with amnestic mild cognitive impairment (aMCI).
Yoon B; Shim YS; Cheong HK; Kim YD; Lee KO; Hong YJ; Oh YS; Na HR; Kim BC; Choi SH; Yang DW
Arch Gerontol Geriatr; 2013; 57(3):292-7. PubMed ID: 23688406
[TBL] [Abstract][Full Text] [Related]
28. Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.
Bangen KJ; Clark AL; Werhane M; Edmonds EC; Nation DA; Evangelista N; Libon DJ; Bondi MW; Delano-Wood L;
J Alzheimers Dis; 2016 Mar; 52(3):849-61. PubMed ID: 27031472
[TBL] [Abstract][Full Text] [Related]
29. Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population.
Riaz M; Huq A; Ryan J; Orchard SG; Tiller J; Lockery J; Woods RL; Wolfe R; Renton AE; Goate AM; Sebra R; Schadt E; Brodtmann A; Shah RC; Storey E; Murray AM; McNeil JJ; Lacaze P
Aging Cell; 2021 Jun; 20(6):e13384. PubMed ID: 34041846
[TBL] [Abstract][Full Text] [Related]
30. Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity.
Lyall DM; Cox SR; Lyall LM; Celis-Morales C; Cullen B; Mackay DF; Ward J; Strawbridge RJ; McIntosh AM; Sattar N; Smith DJ; Cavanagh J; Deary IJ; Pell JP
Brain Imaging Behav; 2020 Oct; 14(5):1468-1476. PubMed ID: 30903549
[TBL] [Abstract][Full Text] [Related]
31. APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.
Qian J; Wolters FJ; Beiser A; Haan M; Ikram MA; Karlawish J; Langbaum JB; Neuhaus JM; Reiman EM; Roberts JS; Seshadri S; Tariot PN; Woods BM; Betensky RA; Blacker D
PLoS Med; 2017 Mar; 14(3):e1002254. PubMed ID: 28323826
[TBL] [Abstract][Full Text] [Related]
32. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
33. Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models.
Cacciottolo M; Wang X; Driscoll I; Woodward N; Saffari A; Reyes J; Serre ML; Vizuete W; Sioutas C; Morgan TE; Gatz M; Chui HC; Shumaker SA; Resnick SM; Espeland MA; Finch CE; Chen JC
Transl Psychiatry; 2017 Jan; 7(1):e1022. PubMed ID: 28140404
[TBL] [Abstract][Full Text] [Related]
34. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
35. Influence of socio-demographic features and apolipoprotein E epsilon 4 expression on the prevalence of dementia and cognitive impairment in a population of 70-74-year olds: the InveCe.Ab study.
Guaita A; Vaccaro R; Davin A; Colombo M; Vitali SF; Polito L; Abbondanza S; Valle E; Forloni G; Ferretti VV; Villani S
Arch Gerontol Geriatr; 2015; 60(2):334-43. PubMed ID: 25466513
[TBL] [Abstract][Full Text] [Related]
36. APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.
Tropea TF; Xie SX; Rick J; Chahine LM; Dahodwala N; Doshi J; Davatzikos C; Shaw LM; Van Deerlin V; Trojanowski JQ; Weintraub D; Chen-Plotkin AS
Mov Disord; 2018 Feb; 33(2):289-297. PubMed ID: 29168904
[TBL] [Abstract][Full Text] [Related]
37. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition.
Wierenga CE; Dev SI; Shin DD; Clark LR; Bangen KJ; Jak AJ; Rissman RA; Liu TT; Salmon DP; Bondi MW
J Cereb Blood Flow Metab; 2012 Aug; 32(8):1589-99. PubMed ID: 22549621
[TBL] [Abstract][Full Text] [Related]
38. No Evidence That Genetic Variation at the Klotho Locus Is Associated With Longevity in Caucasians from the Newcastle 85+ Study and the UK Biobank.
Amin HA; Cordell HJ; Martin-Ruiz C; Robinson L; Kirkwood T; Blakemore AI; Drenos F
J Gerontol A Biol Sci Med Sci; 2022 Mar; 77(3):457-461. PubMed ID: 34893828
[TBL] [Abstract][Full Text] [Related]
39. Interaction with the MAPT H1H1 Genotype Increases Dementia Risk in APOE ε4 Carriers in a Population of Southern India.
Jairani PS; Aswathy PM; Gopala S; Verghese J; Mathuranath PS
Dement Geriatr Cogn Disord; 2016; 42(5-6):255-264. PubMed ID: 27705964
[TBL] [Abstract][Full Text] [Related]
40. Nighttime Blood Pressure Interacts with APOE Genotype to Increase the Risk of Incident Dementia of the Alzheimer's Type in Hispanics.
Melgarejo JD; Aguirre-Acevedo DC; Gaona C; Chavez CA; Calmón GE; Silva ER; de Erausquin GA; Gil M; Mena LJ; Terwilliger JD; Arboleda H; Scarmeas N; Lee JH; Maestre GE
J Alzheimers Dis; 2020; 77(2):569-579. PubMed ID: 32675415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
